| Year |
Citation |
Score |
| 2020 |
Thyparambil SP, Liao W, An E, Bhalkikar A, Heaton R, Sylvester KG, Ling XB. Proteomic profiling to identify therapeutics targets in glioblastoma (GBM). Journal of Clinical Oncology. 38: 2555-2555. DOI: 10.1200/Jco.2020.38.15_Suppl.2555 |
0.372 |
|
| 2018 |
An E, Hong S, An HJ, Thyparambil SP, SELLAPPAN S, Yan D, Tian Y, Cecchi F, Hembrough TA, Kim TJ. Identifying treatment options for SCLC patients with multiplexed clinical proteomic testing. Journal of Clinical Oncology. 36: 8574-8574. DOI: 10.1200/Jco.2018.36.15_Suppl.8574 |
0.329 |
|
| 2015 |
Hembrough T, Liao WL, Hartley CP, Ma PC, Velcheti V, Lanigan C, Thyparambil S, An E, Monga M, Krizman D, Burrows J, Tafe LJ. Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib. Clinical Chemistry. PMID 26585927 DOI: 10.1373/Clinchem.2015.245860 |
0.37 |
|
| 2015 |
Manes NP, Angermann BR, Koppenol-Raab M, An E, Sjoelund VH, Sun J, Ishii M, Germain RN, Meier-Schellersheim M, Nita-Lazar A. Targeted Proteomics-Driven Computational Modeling of Macrophage S1P Chemosensing. Molecular & Cellular Proteomics : McP. 14: 2661-81. PMID 26199343 DOI: 10.1074/Mcp.M115.048918 |
0.383 |
|
| 2015 |
An HJ, An E, Liao W, Kang JH, Burrows J, Hembrough TA, Kim T. Clinical implication of mass-spectrometry-based selected reaction monitoring (SRM) assay in non-small cell lung cancer (NSCLC) patients exhibiting ALK gene rearrangement. Journal of Clinical Oncology. 33: e22145-e22145. DOI: 10.1200/Jco.2015.33.15_Suppl.E22145 |
0.366 |
|
| 2015 |
Ock C, An E, Oh D, Kim T, Lee K, Han S, Im S, Kim T, Liao W, Cecchi F, Blackler A, Thyparambil SP, Hoos WA, Kim WH, Burrows J, et al. Quantitative measurement of HER2 levels by multiplexed mass spectrometry to predict survival in gastric cancer patients treated with trastuzumab. Journal of Clinical Oncology. 33: 4050-4050. DOI: 10.1200/Jco.2015.33.15_Suppl.4050 |
0.34 |
|
| 2015 |
An E, Kim T, Monga M, Bengali K, Drilea A, Reilly J, Darfler M, Burrows J, Hembrough T. Abstract 566: ChemoPlex SRM assay predicts response to specific chemotherapeutic agents in NSCLC Cancer Research. 75: 566-566. DOI: 10.1158/1538-7445.Am2015-566 |
0.35 |
|
| 2015 |
Blackler A, Liao W, Thyparambil S, An E, Cecchi F, Darfler M, Hembrough T, Burrows J. Abstract 3398: Development of a mass spectrometry based antibody-drug conjugate biomarker panel Cancer Research. 75: 3398-3398. DOI: 10.1158/1538-7445.Am2015-3398 |
0.384 |
|
| 2014 |
An E, Narayanan M, Manes NP, Nita-Lazar A. Characterization of functional reprogramming during osteoclast development using quantitative proteomics and mRNA profiling. Molecular & Cellular Proteomics : McP. 13: 2687-704. PMID 25044017 DOI: 10.1074/Mcp.M113.034371 |
0.325 |
|
| 2014 |
An E, Liao W, Thyparambil S, Blackler A, Uzzell J, Bengali K, Darfler M, Burrows J, Hembrough T. Abstract 918: Clinical validation of a multiplexed ChemoPlex SRM assay in FFPE human tumor tissue Cancer Research. 74: 918-918. DOI: 10.1158/1538-7445.Am2014-918 |
0.386 |
|
| 2014 |
An E, Liao W, Thyparambil S, Rodriguez J, Salgia R, Wistuba I, Burrows J, Hembrough T. 489 Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples European Journal of Cancer. 50: 159. DOI: 10.1016/S0959-8049(14)70615-X |
0.303 |
|
| 2014 |
Hembrough T, Liao W, Hartley CP, Thyparambil S, An E, Burrows J, Tafe LJ. Quantification of ALK From Non-Small Cell Lung Cancer (NSCLC) FFPE Tissue by Targeted Mass Spectrometry International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.281 |
0.343 |
|
| 2012 |
Brown KJ, Formolo CA, Seol H, Marathi RL, Duguez S, An E, Pillai D, Nazarian J, Rood BR, Hathout Y. Advances in the proteomic investigation of the cell secretome. Expert Review of Proteomics. 9: 337-45. PMID 22809211 DOI: 10.1586/Epr.12.21 |
0.511 |
|
| 2010 |
An E, Sen S, Park SK, Gordish-Dressman H, Hathout Y. Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Investigative Ophthalmology & Visual Science. 51: 3379-86. PMID 20207970 DOI: 10.1167/Iovs.09-4853 |
0.599 |
|
| 2008 |
An E, Gordish-Dressman H, Hathout Y. Effect of TNF-alpha on human ARPE-19-secreted proteins. Molecular Vision. 14: 2292-303. PMID 19093006 |
0.551 |
|
| 2007 |
An E, Lu X, Flippin J, Devaney JM, Halligan B, Hoffman E, Csaky aK, Hathout Y. Secreted Proteome Profiling in Human RPE Cell Cultures Derived from Donors with Age Related Macular Degeneration and Age Matched Healthy Donors J. Proteome Res. 2006, 5, 2599−2610. Journal of Proteome Research. 6: 1615-1615. DOI: 10.1021/Pr078003Z |
0.581 |
|
| 2006 |
An E, Lu X, Flippin J, Devaney JM, Halligan B, Hoffman EP, Hoffman E, Strunnikova N, Csaky K, Hathout Y. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. Journal of Proteome Research. 5: 2599-610. PMID 17022631 DOI: 10.1021/Pr060121J |
0.623 |
|
| Show low-probability matches. |